Gastric Adenocarcinoma

Showing NaN - NaN of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastric Adenocarcinoma, Carcinomatosis Trial in Houston (Paclitaxel, Dexamethasone, Diphenhydramine)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Carcinomatosis
  • Houston, Texas
    M D Anderson Cancer Center
Aug 7, 2023

Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Jan 26, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Houston, Texas
  • +3 more
Nov 13, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,

Recruiting
  • Gastric Adenocarcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2022

Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

Recruiting
  • Advanced Solid Tumor
  • +18 more
  • PT199
  • Anti-PD-1 monoclonal antibody
  • Huntersville, North Carolina
  • +2 more
Aug 10, 2022

Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I

Recruiting
  • Clinical Stage 0 Gastric Cancer AJCC v8
  • +27 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • PDR001
  • LAG525
  • San Francisco, California
  • +19 more
May 4, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 12, 2022

Gastric Adenocarcinoma Trial in Houston (procedure, drug, other)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Gastrectomy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +12 more
  • Nashville, Tennessee
  • +4 more
Feb 3, 2022

Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8

Recruiting
  • Clinical Stage I Gastric Cancer AJCC v8
  • +15 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 19, 2020

Assessment of What Patients and Healthcare Providers Value

Unknown status
  • Gastric Adenocarcinoma
  • +2 more
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2020

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab)

Completed
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Tucson, Arizona
  • +44 more
Jun 26, 2020

Gastric Adenocarcinoma Trial in Worldwide (Andecaliximab, Placebo, Leucovorin)

Completed
  • Gastric Adenocarcinoma
  • La Jolla, California
  • +133 more
May 11, 2020

NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Birmingham, Alabama
  • +10 more
Jul 17, 2019

Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in Belgium, United Kingdom, United States (OSI-7904L)

Completed
  • Gastroesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • Philadelphia, Pennsylvania
  • +10 more
Feb 17, 2006